Skip to main content
. 2012 Mar;165(5):1526–1542. doi: 10.1111/j.1476-5381.2011.01637.x

Table 2.

Effects of naringenin-6-C-glucoside (NCG), naringenin (NAR) and 17β-oestradiol (E2) on uterine parameters in OVx mice

Parameter Sham OVx NCG-1 NCG-5 mg·kg−1·d−1 NAR-5 E2-5 µg·kg−1·d−1
Uterine weight (mg) 28.8 ± 1.157***,c 7.84 ± 0.191c,z,r 6.9 ± 0.620c,z,r 6.92 ± 0.566c,z,r 10.88 ± 0.815**,c,r 23.55 ± 0.305***,c,z
Total uterine area (µm2) 160.88 ± 3.01***,c 82.39 ± 3.46c,z,r 75.69 ± 3.60c,z,r 82.43 ± 3.95c,z,r 108.59 ± 1.52***,c,r 51.23 ± 4.24***,c,z
Luminal area (µm2) 8.33 ± 0.77***,c 3.04 ± 0.35c,r 3.03 ± 0.31c,r 3.28 ± 0.33c,r 3.63 ± 0.11c,r 7.54 ± 0.39***,c,z
Luminal epithelium height (µm) 0.45 ± 0.02***,c 0.16 ± 0.01c,z,r 0.18 ± 0.27c,z,r 0.17 ± 0.02c,z,r 0.31 ± 0.01***,c,r 0.40 ± 0.02***,c,r
**

P < 0.01

***

P < 0.001 versus OVx

c

P < 0.001 versus sham

z

P < 0.001 versus N

r

P < 0.001 versus E2.

Results are mean ± SEM, n = 10 mice per group.

NCG-1, NCG-5, NCG at 1 or 5 mg·kg−1·day−1; NAR-5, naringenin at 5 mg·kg−1·day−1; E2-5 = E2 at 5 µg·kg−1·day−1.